Results for tag: "Oral Dysplasia Drug"

Oral Dysplasia Drugs are a type of Gastrointestinal Drug used to treat precancerous lesions in the oral cavity. These drugs are typically administered topically, and can be used to treat a variety of conditions, including leukoplakia, erythroplakia, and oral lichen planus. Oral Dysplasia Drugs are designed to reduce the risk of developing oral cancer, and can be used in combination with other treatments such as surgery or radiation therapy. Common side effects of these drugs include dry mouth, sore throat, and burning sensation in the mouth. The Oral Dysplasia Drug market is a rapidly growing segment of the Gastrointestinal Drug market, with a wide range of products available. These drugs are typically prescribed by dentists and oral surgeons, and are available in both prescription and over-the-counter forms. Some companies in the Oral Dysplasia Drug market include GlaxoSmithKline, Pfizer, Merck, and Novartis. Show Less Read more